Wells Fargo Upgrades ZIOPHARM Oncology (ZIOP) to Market Perform
- Apple (AAPL) Tops Q4 EPS by 2c; Issues Solid Outlook
- Wall St. slips on earnings; Apple results due
- Chipotle Mexican Grill (CMG) Posts Q3 EPS of $0.27; Comps Miss Views; Additional Stock Buyback Approved
- Pandora (P) Misses Q3 EPS by 1c, Q4 Revenue Guidance Falls Short
- Panera Bread (PNRA) Tops Q3 EPS by 3c; Raises Outlook
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
Wells Fargo upgraded ZIOPHARM Oncology (NASDAQ: ZIOP) from Underperform to Market Perform.
Shares of ZIOPHARM Oncology closed at $4.86 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: UBS Upgrades Swift Transportation (SWFT) to Buy
- Fossil Group (FOSL): Successful Wearables Launch May Open The Door To Growth - Wells Fargo
- Visa (V) PT Raised to $97 at UBS on Solid Q4
Create E-mail Alert Related CategoriesUpgrades
Related EntitiesWells Fargo
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!